本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bolt Biotherapeutics, Inc.

3.95
+0.22005.90%
盤後3.950.00000.00%19:30 EDT
成交量:7.71萬
成交額:28.95萬
市值:758.18萬
市盈率:-0.24
高:3.96
開:3.72
低:3.57
收:3.73
52周最高:7.20
52周最低:3.13
股本:191.94萬
流通股本:144.06萬
量比:3.14
換手率:5.35%
股息:- -
股息率:- -
每股收益(TTM):-16.3353
每股收益(LYR):-17.8500
淨資產收益率:-111.65%
總資產收益率:-30.73%
市淨率:0.60
市盈率(LYR):-0.22

資料載入中...

2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/14

重要事件披露

Form 8-K - Current report
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/29

重要事件披露

8-K - Current report
2023/03/29

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/14

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]